139 related articles for article (PubMed ID: 30820912)
1. Lymphatic invasion is a cause of local recurrence after wedge resection of primary lung cancer.
Matsuura N; Go T; Fujiwara A; Nakano T; Nakashima N; Tarumi S; Chang SS; Yokomise H
Gen Thorac Cardiovasc Surg; 2019 Oct; 67(10):861-866. PubMed ID: 30820912
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
3. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
5. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
Moon Y; Lee KY; Park JK
World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.
Moon Y; Park JK; Lee KY; Sung SW
Respirology; 2017 Aug; 22(6):1179-1184. PubMed ID: 28382791
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data.
Kelsey CR; Higgins KA; Peterson BL; Chino JP; Marks LB; D'Amico TA; Varlotto JM
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):768-773.e1. PubMed ID: 23856204
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of vascular and lymphovascular invasion in early lung cancer.
Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ
Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic vessel invasion and lymph node metastasis in patients with clinical stage I non-small cell lung cancer.
Kang DY; Lee S
Thorac Cardiovasc Surg; 2014 Sep; 62(6):521-4. PubMed ID: 24905019
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel invasion in pathologic stage I and II non-small cell lung tumors.
Jeon HW; Kim KS; Kim YD; Jo KH; Park HJ; Wang YP; Park JK
Surg Today; 2015 Aug; 45(8):1018-24. PubMed ID: 25424778
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer.
Harada M; Hato T; Horio H
J Thorac Oncol; 2011 Jan; 6(1):48-54. PubMed ID: 21079523
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular space invasion and tumor differentiation are predictors for postoperative recurrence in patients with pathological stage I nonsmall cell lung cancer.
Chen YY; Huang TW; Tsai WC; Lin LF; Cheng JB; Lee SC; Chang H
J Chin Med Assoc; 2014 Aug; 77(8):416-21. PubMed ID: 25028298
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer.
Yilmaz A; Duyar SS; Cakir E; Aydin E; Demirag F; Karakaya J; Yazici U; Erdogan Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):664-70. PubMed ID: 21334917
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]